BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 215614)

  • 21. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization of hearing loss in Paget's disease with calcitonin and etidronate.
    Lando M; Hoover LA; Finerman G
    Arch Otolaryngol Head Neck Surg; 1988 Aug; 114(8):891-4. PubMed ID: 3134037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcitonin in the treatment of Paget's disease of bone.
    Johnston CC
    Ann Intern Med; 1972 Apr; 76(4):665-6. PubMed ID: 4268241
    [No Abstract]   [Full Text] [Related]  

  • 25. Paget's disease: New treatment for an old disease.
    Wallach S
    Am Fam Physician; 1976 Jan; 13(1):78-85. PubMed ID: 130063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical aspects and therapy of Paget's disease (osteitis deformans)].
    Ringe JD
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1207-12. PubMed ID: 6223799
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patient with Paget's disease of bone treated with etidronate disodium.
    Koga K; Kawasaki K; Kohno S; Yamada K; Itoh T; Nonaka K
    Kurume Med J; 1998; 45(4):345-9. PubMed ID: 9914722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biological exploration of Paget's disease].
    Eisinger J; Laponche AM; Roux H; Recordier AM
    Rev Rhum Mal Osteoartic; 1976 Feb; 43(2):105-11. PubMed ID: 131366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer agents in treating Paget's disease of bone.
    Goldfield EB
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract]   [Full Text] [Related]  

  • 31. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurological complications of Paget's disease of bone].
    Foidart M; Reginster JY; Franchimont P
    Rev Med Liege; 1989 Jun; 44(11):396-401. PubMed ID: 2664967
    [No Abstract]   [Full Text] [Related]  

  • 34. Paget's disease of bone.
    Ryan WG
    Annu Rev Med; 1977; 28():143-52. PubMed ID: 140620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy.
    Ryan WG; Schwartz TB
    Arthritis Rheum; 1980 Oct; 23(10):1155-61. PubMed ID: 6158957
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paget's disease: errors to be avoided].
    FourniƩ A; FourniƩ B; Lassoued S
    Rev Prat; 1989 Apr; 39(13):1143-6. PubMed ID: 2499920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal-cord syndrome due to non-compressive Paget's disease of bone: a spinal-artery steal phenomenon reversible with calcitonin.
    Herzberg L; Bayliss E
    Lancet; 1980 Jul; 2(8184):13-5. PubMed ID: 6104224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.